Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexarotene Augmentation for Chronic Schizophrenia
NCT00535574Phase 3Completed
- Sponsor
- Be'er Sheva Mental Health Center
- Start
- Nov 2008
- Primary completion
- Dec 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of bexarotene in schizophrenia, schizoaffective disorder, sponsored by Be'er Sheva Mental Health Center. Started Nov 2008; status: completed.
02
Drugs
bexarotene
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00535574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00535574.